Optinose Announces Reporting Date for Second Quarter 2024 Financial Results
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on ear, nose and throat (ENT) and allergy treatments, has announced its plans to report second quarter 2024 financial results and corporate updates. The company will release this information before market open on Thursday, August 8, 2024. Following the release, Optinose will host a conference call and webcast at 8:00 a.m. Eastern Time on the same day.
Investors and interested parties can access the live webcast through the Investors section of Optinose's website. For those wishing to participate via telephone, pre-registration is required. A replay of the webcast will be available on the company's website for 60 days after the event.
Optinose (NASDAQ:OPTN), un'azienda farmaceutica focalizzata su trattamenti per le orecchie, naso e gola (ENT) e allergie, ha annunciato i suoi piani per riportare i risultati finanziari del secondo trimestre 2024 e aggiornamenti aziendali. L'azienda rilascerà queste informazioni prima dell'apertura del mercato giovedì 8 agosto 2024. Dopo il rilascio, Optinose ospiterà una conference call e un webcast alle 8:00 ora orientale dello stesso giorno.
Gli investitori e le parti interessate possono accedere al webcast dal vivo attraverso la sezione Investitori del sito web di Optinose. Per coloro che desiderano partecipare telefonicamente, è necessaria la registrazione anticipata. Una registrazione del webcast sarà disponibile sul sito dell'azienda per 60 giorni dopo l'evento.
Optinose (NASDAQ:OPTN), una empresa farmacéutica centrada en tratamientos para oídos, nariz y garganta (ENT) y alergias, ha anunciado sus planes para informar sobre los resultados financieros del segundo trimestre de 2024 y actualizaciones corporativas. La empresa publicará esta información antes de la apertura del mercado el jueves 8 de agosto de 2024. Tras la publicación, Optinose realizará una llamada de conferencia y un webcast a las 8:00 a.m. hora del Este el mismo día.
Los inversores y partes interesadas pueden acceder al webcast en vivo a través de la sección de Inversores en el sitio web de Optinose. Para aquellos que deseen participar por teléfono, se requiere preinscripción. Una repetición del webcast estará disponible en el sitio web de la empresa durante 60 días después del evento.
옵티노즈(나스닥:OPTN)는 귀, 코 및 목(ENT) 및 알레르기 치료에 중점을 둔 제약회사로, 2024년 2분기 재무 결과 및 기업 업데이트를 발표할 계획을 알렸습니다. 회사는 이 정보를 2024년 8월 8일 목요일 시장 개장 전에 발표할 것입니다. 발표 후, 옵티노즈는 같은 날 동부 표준시 기준 오전 8:00에 전화 회의 및 웹캐스트를 진행할 예정입니다.
투자자 및 관계자는 옵티노즈 웹사이트의 투자자 섹션을 통해 실시간 웹캐스트에 접속할 수 있습니다. 전화로 참여를 원하는 경우 사전 등록이 필요합니다. 웹캐스트의 재생은 행사 후 60일 동안 회사 웹사이트에서 제공됩니다.
Optinose (NASDAQ:OPTN), une société pharmaceutique axée sur les traitements des oreilles, du nez et de la gorge (ENT) et des allergies, a annoncé son intention de publier les résultats financiers du deuxième trimestre 2024 et des mises à jour d'entreprise. L'entreprise publiera ces informations avant l'ouverture du marché le jeudi 8 août 2024. Après la publication, Optinose animera une conférence téléphonique et un webinaire à 8h00, heure de l'Est le même jour.
Les investisseurs et les parties intéressées peuvent accéder au webinaire en direct via la section Investisseurs du site d'Optinose. Pour ceux qui souhaitent participer par téléphone, une pré-inscription est requise. Un enregistrement du webinaire sera disponible sur le site de l'entreprise pendant 60 jours après l'événement.
Optinose (NASDAQ:OPTN), ein in der Pharmazie tätiges Unternehmen, das sich auf Behandlungen für Ohren, Nase und Hals (ENT) sowie Allergien konzentriert, hat Pläne angekündigt, die Finanzergebnisse des zweiten Quartals 2024 und Unternehmensneuigkeiten zu berichten. Das Unternehmen wird diese Informationen vor Markteröffnung am Donnerstag, den 8. August 2024, veröffentlichen. Nach der Veröffentlichung wird Optinose am selben Tag um 8:00 Uhr Eastern Time eine Konferenzschaltung und ein Webcast abhalten.
Investoren und Interessierte können über den Bereich Investoren auf der Website von Optinose auf den Live-Webcast zugreifen. Für diejenigen, die telefonisch teilnehmen möchten, ist eine vorherige Registrierung erforderlich. Eine Wiederholung des Webcasts ist 60 Tage nach der Veranstaltung auf der Unternehmenswebsite verfügbar.
- None.
- None.
Conference Call and Webcast to be held August 8, 2024, at 8:00 a.m. Eastern Time
YARDLEY, Pa., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the second quarter 2024 and corporate updates, before market open, on Thursday, August 8, 2024.
Company to Host Conference Call
Members of the Company’s leadership team will host a conference call to discuss financial results and corporate updates. The call is scheduled to start at 8:00 a.m. Eastern Time on Thursday, August 8, 2024.
Participants may access the conference call live via webcast by visiting the Investors section of Optinose’s website at http://ir.optinose.com/event-calendar. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a personal PIN that can be used to access the call. In addition, a replay of the webcast will be available on the Company website for 60 days following the event.
About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
FAQ
When will Optinose (OPTN) report its Q2 2024 financial results?
What time is Optinose's (OPTN) Q2 2024 earnings conference call?
How can investors access Optinose's (OPTN) Q2 2024 earnings call?
Will there be a replay available for Optinose's (OPTN) Q2 2024 earnings call?
